FTRE
Fortrea Holdings·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 0
Bearish signal 3
RSI Overbought
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About FTRE
Fortrea Holdings Inc.
A leading global CRO (Contract Research Organization)
Healthcare Equipment and Supplies
01/31/2023
07/03/2023
NASDAQ Stock Exchange
15,500
12-31
Common stock
8 Moore Drive
Durham
North Carolina 27713
--
Fortrea Holdings Inc.was incorporated in Delaware on January 31, 2023. The Company is a leading global contract research organization (" CRO ") providing clinical development, patient access solutions and consulting to the life sciences industry. The company provides Phase I to Phase IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services.
Company Financials
EPS
FTRE has released its 2025 Q3 earnings. EPS was reported at 0.12, versus the expected 0.16, missing expectations. The chart below visualizes how FTRE has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
FTRE has released its 2025 Q3 earnings report, with revenue of 701.30M, reflecting a YoY change of 3.91%, and net profit of -15.90M, showing a YoY change of 43.01%. The Sankey diagram below clearly presents FTRE's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
